Literature DB >> 7715478

Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years.

F P Groeneveld1, F P Bareman, R Barentsen, H J Dokter, A C Drogendijk, A W Hoes.   

Abstract

The aim of the present study was to ascertain the cumulative incidence of first hormone replacement therapy (HRT) and the factors that predict its prescription. In a general population 1689 women were followed for 9 months in order to trace first HRT prescriptions. Determinants (well-being, attitude towards menopause, menopausal status and another 9 variables) were measured by means of a questionnaire. Data analyses were performed for all women and for women with or without typical climacteric complaints. The cumulative 9 month incidence of HRT was 6.2%. For women without typical complaints a lower level of well-being (odds ratio 5.5; 95% CI 1.9-15.5) and the former use of the contraceptive pill (odds ratio 4.6%; 95% CI 1.0-20.5) were independently associated with HRT prescription. For women with typical complaints a positive attitude towards 'menopause should be treated' (odds ratio 3.8; 95% CI 1.8-8.0) was a determinant of HRT prescription. The cumulative incidence of HRT prescription is high, but from additional data it is apparent that within a period of 1 year and 9 months the majority of women stop taking HRT. For women without typical complaints, physicians prescribe HRT five times more often to those with a lower level of well-being. For women with typical complaints the physician's prescription is primarily related to the woman's attitude towards (medical) treatment of the menopause.

Entities:  

Mesh:

Year:  1994        PMID: 7715478     DOI: 10.1016/0378-5122(94)90003-5

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  4 in total

Review 1.  Clinical nutrition: 2. The role of nutrition in the prevention and treatment of adult osteoporosis.

Authors:  S A Atkinson; W E Ward
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

2.  Salmon calcitonin nasal spray : An effective alternative to estrogen therapy in select postmenopausal women.

Authors:  L V Avioli
Journal:  Endocrine       Date:  1996-10       Impact factor: 3.633

3.  Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.

Authors:  Eva Lydeking-Olsen; Jens-Erik Beck-Jensen; Kenneth D R Setchell; Trine Holm-Jensen
Journal:  Eur J Nutr       Date:  2004-04-14       Impact factor: 5.614

4.  Assessment of soy phytoestrogens' effects on bone turnover indicators in menopausal women with osteopenia in Iran: a before and after clinical trial.

Authors:  Arezoo Haghighian Roudsari; Farideh Tahbaz; Arash Hossein-Nezhad; Bahram Arjmandi; Bagher Larijani; Seyed Masoud Kimiagar
Journal:  Nutr J       Date:  2005-10-29       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.